IRA C. SPECTORCEO, CO-FOUNDER
PhD, University of Medicine & Dentistry, NJ (Rutgers), MBA,
Drexel University
Wyeth, Pfizer, Allergan, ICON;
experienced drug developer on 34 NDAs and co-founder of
4 prior startups, 30 years of experience
MARK FEITELSONCSO, CO-FOUNDER
PhD, Immunovirology, UCLA Geffen Medical School;
Co-inventor, Professor at Temple University
World-class
expert in liver disease; advisor to Chiron Diagnostics,
Biogen, Immune Response Corp, Pharmasset &
amp; QuadPharma, Ribozyme, Maxygen, USINO, and Theravectys, 35 years of experience
ALLA ARZUMANYANCDO, CO-FOUNDER
PhD, Biotechnology, Yerevan University, Armenia;
Co-inventor; Assistant Professor at Temple and
Jefferson University;
Eexpert in stem cell cancers,
HBV and GI microbiome, worked with HEC
(Sunshine Lake Pharma Co.), Theravectys, and
ThirdLaw, 25 years of experience
Shawn O’BrienChairman
, Western University
Serial life sciences entrepreneur; Founder, Consultant, C-Suite and Board positions at multiple startups including: Genomind, Cipher Pharmaceuticals, Melanovus Oncology, Cyrano Nasal Sciences Altherx, Solstice Neurosciences; and Executive postitions at AstraZeneca
MBA, The Wharton School, Unversity of Pennsylvania, BA Economics, Princeton University.
Board Member, Advisor, C-Level Life Science and Investment Banking Executive. Biotechnology Startup Veteran; South Rampart Pharma, Virtuviae, BCI Life Sciences, Sharp Edge Labs, Emmaus Life Sciences, Sanuthera, Tyme Technolgies, BeyondSpring, Pharmaceuticals, Motif Bio, Neostem, Hemispherx Biopharma, StemCyte, Locus Pharmaceuticals. Investmetn Banker; Legg Mason, Lehman Brothers
